The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

TensorFlow is an open source machine learning framework developed by Google, designed to build and train AI models for a wide ...

A newly approved pain medication, suzetrigine, is the first nonopioid analgesic in 25 years to receive clearance from the U.S ...

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

A modern control scheme and HD textures clash awkwardly with the boxy old levels of Lara's past, in three of her least ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

A new study shows how the brain reorganizes itself in the first few months after a stroke to improve the ability to speak ...

Human evolution has revolved around food, from identifying and foraging for it to growing and preparing it. Carnegie Mellon University researchers have identified a region in the brain's visual cortex ...

Having a word “on the tip of the tongue” has happened to all of us. Behind this everyday phenomenon lie complex brain ...